When and how should muscle relaxants (e.g., baclofen, tizanidine, diazepam, dantrolene) be used safely in adolescents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Muscle Relaxant Use in Adolescents

Muscle relaxants should be used cautiously and selectively in adolescents, with baclofen, tizanidine, and dantrolene preferred over benzodiazepines for spasticity-related conditions, while avoiding routine use for acute musculoskeletal pain where evidence of benefit is lacking.

Clinical Context and Indications

Muscle relaxants in adolescents are primarily indicated for spasticity from cerebral palsy or neurological conditions, not for common musculoskeletal complaints. The distinction between antispasticity agents (baclofen, tizanidine, dantrolene) and antispasmodic agents matters significantly for appropriate prescribing 1.

For Spasticity (Cerebral Palsy, Neurological Conditions)

First-line approach:

  • Start with non-pharmacological interventions: positioning, passive stretching, range of motion exercises, splinting 2
  • Reserve medications for spasticity causing pain, functional impairment, or hygiene problems

Medication selection hierarchy:

  1. Tizanidine - Consider as first-line oral agent

    • Evidence shows efficacy without loss of motor strength 2
    • Dose-dependent sedation is the main concern 3
    • Start low and titrate slowly
    • Critical warning: Contraindicated with ciprofloxacin or fluvoxamine; significant interactions with CYP1A2 inhibitors (oral contraceptives, cimetidine, verapamil) causing hypotension and excessive sedation 4, 3
    • Must be tapered slowly if discontinuing to avoid rebound hypertension and tachycardia 4, 3
  2. Baclofen - Consider as alternative

    • FDA-approved for spasticity 2
    • May cause significant sedation 2
    • Critical safety concern: Abrupt withdrawal causes severe symptoms including hallucinations, seizures, fever, and tachycardia 4
    • Never stop suddenly - taper gradually 5
    • Limited evidence in adolescents specifically 6
  3. Dantrolene - Third-line option

    • Limited trial data supporting use 2
    • Benefit: no cognitive side effects 2
    • Risk: hepatotoxicity (though usually reversible) 7
    • Requires monitoring
  4. Diazepam - Avoid in most situations

    • Strongly recommend against for neurological recovery periods 2
    • Deleterious effects on recovery plus sedation 2
    • Risk of abuse, addiction, and tolerance 7
    • Only consider for short-term use when other options have failed 6, 8

For Acute Musculoskeletal Pain

Do not routinely prescribe muscle relaxants for adolescents with acute low back pain or muscle strain.

The evidence is clear: muscle relaxants provide no benefit over placebo when combined with NSAIDs for acute musculoskeletal pain 9, 10. A 2022 study comparing seven skeletal muscle relaxants found no statistically significant differences between any agent and placebo when patients also received NSAIDs 9. A 2019 trial specifically testing baclofen, metaxalone, and tizanidine plus ibuprofen versus ibuprofen alone showed identical functional outcomes at one week 10.

Recommended approach for acute musculoskeletal pain:

  • NSAIDs (ibuprofen) as first-line
  • Patient education (10-minute session shown effective) 10
  • Avoid muscle relaxants - they add only sedation and side effects without improving outcomes

Critical Safety Considerations in Adolescents

Sedation and CNS Depression

All muscle relaxants cause sedation that is additive with alcohol and other CNS depressants 3, 5. Warn adolescents explicitly about:

  • No driving or operating machinery
  • No alcohol consumption
  • Increased risk when combined with other sedating medications

Withdrawal Risks

Never abruptly discontinue:

  • Baclofen: Life-threatening withdrawal with hallucinations, seizures, hyperthermia 4, 5
  • Tizanidine: Rebound hypertension, tachycardia, hypertonia 4, 3

Drug Interactions

  • Tizanidine + oral contraceptives: 50% reduction in clearance, requiring dose reduction 3
  • Tizanidine + CYP1A2 inhibitors: Severe hypotension and bradycardia 4, 3

Abuse Potential

  • Carisoprodol: Controlled substance with barbiturate-like effects, high abuse potential - avoid in adolescents 4
  • Diazepam: Benzodiazepine with addiction risk 7

Practical Prescribing Algorithm

Step 1: Confirm indication

  • Spasticity with functional impairment, pain, or hygiene issues? → Proceed
  • Acute musculoskeletal pain? → NSAIDs only, no muscle relaxant

Step 2: Maximize non-pharmacological interventions first

  • Physical therapy, stretching, positioning, splinting

Step 3: Select medication

  • First choice: Tizanidine (check for contraindications, especially oral contraceptives)
  • Second choice: Baclofen
  • Avoid: Diazepam except as last resort for short-term use

Step 4: Start low, go slow

  • Titrate gradually to minimize sedation
  • Monitor for effectiveness on pain and function, not just tone

Step 5: Plan for discontinuation

  • Always taper slowly over days to weeks
  • Never allow abrupt cessation

Common Pitfalls to Avoid

  1. Prescribing muscle relaxants for acute back pain - No evidence of benefit over NSAIDs alone 9, 10
  2. Abrupt discontinuation - Risk of severe withdrawal, especially with baclofen 4
  3. Ignoring drug interactions - Particularly tizanidine with oral contraceptives or CYP1A2 inhibitors 4, 3
  4. Using diazepam as first-line - Contraindicated in neurological recovery, abuse potential 2, 7
  5. Prescribing carisoprodol - High abuse potential, inappropriate for adolescents 4

The evidence base for muscle relaxants in adolescents remains limited 6, with most data extrapolated from adult studies. When medications are necessary for spasticity, prioritize agents with better safety profiles (tizanidine, baclofen) over benzodiazepines, ensure proper monitoring, and maintain realistic expectations about functional improvement versus tone reduction.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.